Translational Development Acquisition Corp.
TDAC
$10.17
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -59.57% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -59.57% | -- | -- | -- | |
| Operating Income | 59.57% | -- | -- | -- | |
| Income Before Tax | 85.40% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 85.40% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 85.40% | -- | -- | -- | |
| EBIT | 59.57% | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | 85.81% | -- | -- | -- | |
| Normalized Basic EPS | 85.87% | -- | -- | -- | |
| EPS Diluted | 85.81% | -- | -- | -- | |
| Normalized Diluted EPS | 85.87% | -- | -- | -- | |
| Average Basic Shares Outstanding | 8.46% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 8.46% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |